Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01015157
Other study ID # SEAM1
Secondary ID
Status Completed
Phase N/A
First received August 5, 2009
Last updated January 4, 2010
Start date July 2009
Est. completion date December 2009

Study information

Verified date January 2010
Source Clinique de l'Anjou
Contact n/a
Is FDA regulated No
Health authority France: Institutional Ethical Committee
Study type Interventional

Clinical Trial Summary

Study objectives :

Primary endpoint is to a assess the change in blood loss (originating from stapling the stomach) with the use of Seamguard reinforcement Secondary endpoint is to evaluate the difference in leak rate

Methods :

Prospective. Randomized study. Published data does not allow for clear determination of the number of patients required for the study. Based on our own experience. The investigators estimate that the average postoperative blood loss is 200ml with a standard deviation of 100ml over 3 days. Based on this assumption. A total number of patients (control + Seamguard groups) of 60 is required if the expected reduction of the mean drainage volume is 100ml and 82 patients for an expected drainage volume reduction of 85ml.

All patients candidates to a laparoscopic gastric bypass will be enrolled in the study Under the conditions this is a primary bariatric procedure (no revision allowed)., no history of hiatal surgery such as anti-reflux nor significant upper abdominal surgery. The only associated surgical procedure allowed is the cholecystectomy.

Patients' inclusion :

Will be done immediately before surgical procedure following acceptance of a written consent.

Bleeding from liver or slpeen injury will lead to patient's exclusion.

Methods :

Surgical procedures are identical for the 2 surgeons of the study (GB and PT) with 30-50ml gastric pouch. Linear. side to side. Antegastric and antecolic gastrojejunal anstomosis . Use of Echelon 60 linear stapler with GOLD cartridges on stomach. Blue to perform the gastrojejunal anastomosis and white on Small bowel. Peroperativeblood loss and need to apply clips or stitches on the gastric staple line are recorded. Operation time and patient information (BMI. Comorbidities) are recorded as well any noticeable or unexpected event.

Postoperative blood loss is assessed by at least 1 abdominal closed circuit suction drain left for a minimum of 3 days (removal on postop day 3 at the earliest).

In addition hemoglobin and red cell count is performed on postop day 1 and 2. Absence of leakage is confirmed by methylene blue test perop as well as on postop day 1 before resuming fluids and on postop day 2 by a gastrograffin swallow. Drinks and food are resumed according to the standard practice between postop day 1 and postop day 2.

Duration of the hospital stay and postoperative course will be documented. Early follow up is clinically done at 1 month postop without any specific radiological or biological examination.

Data collection Will be done on a form during and after the procedure

BLOOD LOSS : peroperative volume as well as daily drainage output (postop day 1. 2 and 3) as well as the sum of the 3 postop days.

Hemoglobin change is recorded on day 1 and 2. Need to leave drain(s) for more than 3 days is recorded.

Study completion :

Estimated time to complete the study based on the current experience is between 5 and 7 months. Sudy is closed 1 month after the last inclusion.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date December 2009
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- all primary laparoscopic Roux-en-Y gastric bypasses for morbid obesity

Exclusion Criteria:

- additional procedures except cholecystectomy, peroperative bleeding from spleen or liver injury

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Procedure:
Roux-en-Y laparoscopic gastric bypass for morbid obesity
Primary bariatric surgery. Standard laparoscopic procedure with linear stapling divising of the stomach (Echelon 60 stapler, GOLD cartridges) with or with Seamguard reinforcement

Locations

Country Name City State
France Clinique de l'Anjou Angers

Sponsors (1)

Lead Sponsor Collaborator
Clinique de l'Anjou

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood loss volume per and postoperatively, additional hemostatic measures peroperatively, hemoglobin levels postoperatively 3 days postoperatively Yes
Secondary gastrojejunal anastomosis leakage rate: clinical and radiological postoperative day 2 (gastrograffin swallow) Yes
See also
  Status Clinical Trial Phase
Completed NCT00535600 - Effects of Bariatric Surgery on Insulin
Not yet recruiting NCT01652105 - Randomized Trial of Preoperative Diets Before Bariatric Surgery N/A
Completed NCT01013051 - Effect of Gastric Bypass on the Absorption of Metformin N/A
Completed NCT04082923 - Effect of Meal Texture on Glucose-metabolism and Gut Hormone Response After Bariatric Surgery N/A
Completed NCT01867255 - Study to Examine the Effect of Gastric Bypass Surgery on Venlafaxine ER Blood Levels Phase 1
Active, not recruiting NCT00996294 - Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI) N/A
Completed NCT00549237 - Perioperative Nutrition in Gastric Bypass Surgery N/A
Completed NCT00488423 - Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery Phase 1
Completed NCT02819037 - Small Intestinal Bacterial Overgrowth Obese N/A
Completed NCT01130922 - Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass Phase 4
Terminated NCT02483598 - Mechanistic Investigation Of Intestinal Cytochrome p450 3A4 Following Roux-en-Y Surgery And Its Effect on Plasma Concentrations of Buspirone Phase 4
Recruiting NCT04832282 - Napoleon Measurement of Gastrojejunal Anastomosis Early Phase 1
Completed NCT04332289 - Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.
Completed NCT06298162 - Assessment of Pouch Emptying With MRI After Roux-en-Y Gastric Bypass
Recruiting NCT02823665 - The Effects of Bariatric Surgeries on Glucose Metabolism Early Phase 1
Recruiting NCT02118844 - Laparoscopic Bariatric Surgery: Impact of Deep Neuromuscular Block on Surgical Conditions Phase 4
Completed NCT01330914 - Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton
Completed NCT01138475 - Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery Phase 3
Completed NCT00841009 - Effect of Gastric Bypass-induced Weight Loss on Myocardial Structure, Function and Metabolism N/A
Recruiting NCT05640947 - Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass N/A